177 related articles for article (PubMed ID: 37113393)
1. Exploring the mechanism of an active ingredient of ginger, dihydrocapsaicin, on triple negative breast cancer based on network pharmacology and
Luo L; Chen Y; Ma Q; Huang Y; Hong T; Shu K; Liu Z
Oncol Lett; 2023 May; 25(5):195. PubMed ID: 37113393
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
[TBL] [Abstract][Full Text] [Related]
3. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
4. Exploring the molecular targets and mechanisms of [10]-Gingerol for treating triple-negative breast cancer using bioinformatics approaches, molecular docking, and
Huang P; Zhou P; Liang Y; Wu J; Wu G; Xu R; Dai Y; Guo Q; Lu H; Chen Q
Transl Cancer Res; 2021 Nov; 10(11):4680-4693. PubMed ID: 35116323
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
Zhao M; Fu L; Xu P; Wang T; Li P
Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
[TBL] [Abstract][Full Text] [Related]
8. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
9. Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification.
Deng Z; Chen G; Shi Y; Lin Y; Ou J; Zhu H; Wu J; Li G; Lv L
Front Pharmacol; 2022; 13():920514. PubMed ID: 36003508
[No Abstract] [Full Text] [Related]
10. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
11. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer.
Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
[TBL] [Abstract][Full Text] [Related]
13. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
14. Exploring the active ingredients and potential mechanisms of action of sinomenium acutum in the treatment of rheumatoid arthritis based on systems biology and network pharmacology.
Gong N; Wang L; An L; Xu Y
Front Mol Biosci; 2023; 10():1065171. PubMed ID: 36923645
[No Abstract] [Full Text] [Related]
15. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
[TBL] [Abstract][Full Text] [Related]
16. Network Pharmacology Study on the Underlying Mechanism of Danggui-Kushen Herb Pair in Adjuvant Chemotherapeutics against Breast Cancer.
Hu Y; He J; Xu Y
Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38275061
[TBL] [Abstract][Full Text] [Related]
17. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.
Fu S; Zhou Y; Hu C; Xu Z; Hou J
BMC Complement Med Ther; 2022 Aug; 22(1):210. PubMed ID: 35932042
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the Molecular Mechanism of Polygonati Rhizoma in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Zhao J; Lin F; Liang G; Han Y; Xu N; Pan J; Luo M; Yang W; Zeng L
Front Endocrinol (Lausanne); 2021; 12():815891. PubMed ID: 35069454
[TBL] [Abstract][Full Text] [Related]
20. The potential mechanism of Bletilla striata in the treatment of ulcerative colitis determined through network pharmacology, molecular docking, and in vivo experimental verification.
Gong S; Lv R; Fan Y; Shi Y; Zhang M
Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):983-1000. PubMed ID: 36576506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
